These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 27450174

  • 1. [Severe thrombocytopenia and agranulocytosis associated with metamizole].
    Fernández García PL, Ibáñez Camacho MF, López Pérez E.
    Med Clin (Barc); 2016 Oct 21; 147(8):e43-e44. PubMed ID: 27450174
    [No Abstract] [Full Text] [Related]

  • 2. [Dual agranulocytosis episode likely resulting from metamizole use].
    Hemmersbach-Miller M, Conde Martel A, Acosta Artiles M, Suárez Ortega S.
    Farm Hosp; 2005 Mar 21; 29(2):148-50. PubMed ID: 16045431
    [No Abstract] [Full Text] [Related]

  • 3. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
    Stamer UM, Gundert-Remy U, Biermann E, Erlenwein J, Meiβner W, Wirz S, Stammschulte T.
    Schmerz; 2017 Feb 21; 31(1):5-13. PubMed ID: 27766404
    [Abstract] [Full Text] [Related]

  • 4. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
    Celeketić D, Trpković A, Cvetković Z.
    Vojnosanit Pregl; 2005 Jan 21; 62(1):79-82. PubMed ID: 15715354
    [Abstract] [Full Text] [Related]

  • 5. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C, Likar R.
    Schmerz; 2014 Dec 21; 28(6):584-90. PubMed ID: 25199942
    [Abstract] [Full Text] [Related]

  • 6. [Agranulocytosis in a patient treated with metamizole and clopidogrel].
    Kummer O, Haschke M, Tuchscherer D, Lampert M, Martius F, Krähenbühl S.
    Praxis (Bern 1994); 2006 Nov 08; 95(45):1743-5; quiz 1746-7. PubMed ID: 17205929
    [No Abstract] [Full Text] [Related]

  • 7. [Methamizole-induced agranulocytosis].
    Pedrazas López D, de Pablo Márquez B, García Font D, Sánchez García E.
    Med Clin (Barc); 2016 Apr 01; 146(7):e41. PubMed ID: 26602309
    [No Abstract] [Full Text] [Related]

  • 8. Chronic use of metamizole: not so safe after all?
    Vuik FE, Koehestanie P, Herbers AH, Terhaar Sive Droste JS.
    Neth J Med; 2017 Mar 01; 75(2):81-83. PubMed ID: 28276328
    [Abstract] [Full Text] [Related]

  • 9. Dipyrone (metamizole) use in the United States: a lethal tango?
    Moorman J.
    South Med J; 2006 Sep 01; 99(9):916. PubMed ID: 17004522
    [No Abstract] [Full Text] [Related]

  • 10. [Case Report - Metamizole-Induced Agranulocytosis].
    Gonnert FA, Meißner W.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 May 01; 53(5):388-394. PubMed ID: 29772595
    [Abstract] [Full Text] [Related]

  • 11. Acute renal failure and severe thrombocytopenia associated with metamizole.
    Redondo-Pachon MD, Enriquez R, Sirvent AE, Millan I, Romero A, Amorós F.
    Saudi J Kidney Dis Transpl; 2014 Jan 01; 25(1):121-5. PubMed ID: 24434395
    [Abstract] [Full Text] [Related]

  • 12. [Clinical otorhinolaryngological symptoms of metamizole-induced agranulocytosis].
    Send T, Westermann S, Eichhorn KW, Jakob M.
    HNO; 2015 Mar 01; 63(3):215-9. PubMed ID: 25515122
    [Abstract] [Full Text] [Related]

  • 13. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
    Işık M, Kaya Z, Belen FB, Aktaş AT, Tezer H, Gürsel T.
    J Pediatr Hematol Oncol; 2014 Jan 01; 36(1):e46-8. PubMed ID: 23007418
    [Abstract] [Full Text] [Related]

  • 14. The incidence of metamizole sodium-induced agranulocytosis in Poland.
    Maj S, Lis Y.
    J Int Med Res; 2002 Jan 01; 30(5):488-95. PubMed ID: 12449518
    [Abstract] [Full Text] [Related]

  • 15. [Agranulocytosis from metamizole: a potential problem for the British population].
    Mérida Rodrigo L, Faus Felipe V, Poveda Gómez F, García Alegría J.
    Rev Clin Esp; 2009 Apr 01; 209(4):176-9. PubMed ID: 19457324
    [Abstract] [Full Text] [Related]

  • 16. Dipyrone and agranulocytosis: what is the risk?
    Edwards JE, McQuay HJ.
    Lancet; 2002 Nov 09; 360(9344):1438. PubMed ID: 12433507
    [No Abstract] [Full Text] [Related]

  • 17. Advise against metamizole.
    Neumann J.
    Dtsch Arztebl Int; 2009 Jan 09; 106(4):55-6; author reply 56. PubMed ID: 19564968
    [No Abstract] [Full Text] [Related]

  • 18. Dipyrone and agranulocytosis: what is the risk?
    Schönhöfer P, Offerhaus L, Herxheimer A.
    Lancet; 2003 Mar 15; 361(9361):968-9. PubMed ID: 12648993
    [No Abstract] [Full Text] [Related]

  • 19. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
    Huber M, Andersohn F, Sarganas G, Bronder E, Klimpel A, Thomae M, Konzen C, Kreutz R, Garbe E.
    Eur J Clin Pharmacol; 2015 Feb 15; 71(2):219-27. PubMed ID: 25378038
    [Abstract] [Full Text] [Related]

  • 20. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F, Bantel C, Jobski K.
    Basic Clin Pharmacol Toxicol; 2020 Feb 15; 126(2):116-125. PubMed ID: 31449718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.